8.54
Agenus Inc (AGEN) 最新ニュース
Agenus (AGEN) Moves 82.7% Higher: Will This Strength Last? - Eastern Progress
Agenus Announces Peer-Reviewed Publication Linking BOT+BAL’s Dura - The National Law Review
Agenus (AGEN) Stock Jumps 8.73% to $7.85, Pressing Toward Key ResistanceStock Buy Zone - dars.gov.et
Agenus Stock Price Forecast. Should You Buy AGEN? - StockInvest.us
Agenus Initiated at Buy by Chardan Capital - Moomoo
Agenus Inc (AGEN) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
New Agenus (AGEN) director receives 7,500 stock options - Stock Titan
Spouse-held shares feature in Agenus (AGEN) director's stake - Stock Titan
September Stakeholder Webcast on ROBBIN Phase 3 and Neoadjuvant ImmunotherapyAgenus - Oncodaily
Agenus Inc Share PriceAGEN, RNS News, Articles, Quotes, & Charts (NASDAQ:AGEN) - Proactive financial news
AGEN S-3 FilingsAgenus Inc. SEC S-3 - stocktitan.net
Agenus Inc. (AGEN) Shareholder/Analyst CallSlideshow (NASDAQ:AGEN) 2026-09-11 - Seeking Alpha
BOT+BAL: Three-Year Overall Survival Data in Recurrent Ovarian Cancer – Agenus - Oncodaily
Agenus to Present Three-Year Overall Survival Data for BOT+BAL in Recurrent Ovarian Cancer at IGCS 2026 - BioSpace
Agenus to Present 3-Year Overall Survival Data for BOT+BAL in Recurrent Ovarian Cancer at IGCS 2026 - oncodaily.com
GOOG: Alphabet IncOrdinary SharesClass C Latest Stock Price, Analysis, News and Trading Ideas - Stocktwits
Agenus Company Profile & Introduction - moomoo.com
Agenus to Participate in Upcoming September Investor Conferences - Business Wire
Immigrant Entrepreneur Garo H. Armen Of Agenus Inc. Riccardo Braschi (I0EURkuuPl) - Mshale
New Phase 2 NEST Results Support Neoadjuvant BOT+BAL in Colon Cancer – Agenus - Oncodaily
Agenus reports survival data for colorectal cancer treatment By Investing.com - Investing.com South Africa
Agenus Announces Peer-Reviewed Publication Linking BOT+BAL’s Durable Survival in MSS Metastatic Colorectal Cancer to Its Distinct Immune-Priming Mechanism - Yahoo Finance
Agenus reports survival data for colorectal cancer treatment - Investing.com
Agenus Inc: Shareholders Revolt Over Executive Pay! My Thoughts. Tampa Bay Rays (VzxHMd1TNP) - Mshale
Agenus Inc.AGEN Stock Chart Technical Analysis For 09-21-2020 Sporting Cp (0os72ROBex) - Mshale
Agenus Announces Updated NEST Phase 2 Publication Reporting Deep Pathologic Responses and No Observed Recurrences with Neoadjuvant BOT+BAL in Resectable Colon Cancer - Yahoo Finance
🔴 Agenus Inc. AGEN Stock Trading Facts 🔴 Gianna Nannini (9cYwfB9Crl) - Mshale
Agenus | Learn How I Turned $15,253 Into $1,613,442 Trading Biotech Stocks Donald Gibb (Gf1su3sDdD) - Mshale
AGEN Stock Analysis | Agenus Inc Stock Update & Chart Breakdown Traffic Stop (vDz5v0ltyg) - Mshale
Bold Move By Agenus: Cutting Costs By 60% To Focus On Groundbreaking Cancer Treatments Nikoloz Basilashvili (41VwNJliWR) - Mshale
A.G.E.N.U.S. 8-K: My Take On The C.F.I.U.S. Delay Ctv News Ottawa (HFy9tZJhiU) - Mshale
Why Agenus (AGEN Stock) Just Rocketed Up—Buy Now Or Too Late? Cigarette (l3DDhgoK4D) - Mshale
Insider Trading AGEN Agenus Inc 2021 05 18 Blowing Dust Advisory (aETsN3n1J0) - Mshale
Agenus Inc AGEN CEO Garo Armen On Q4 2019 Results David Muir (NjcFXnx049) - Mshale
Agenus (AGEN) Chart: Ends Down by 5.19% at $7.67 in Latest Trading; Current Setup: $7.29 and $8.05 Define the Nearby Reference Levels in the Available RecordDescending Triangle - careplusvn.com
Agenus Inc (AGEN) Stock Forecast, Price Targets and Analysts Predictions - GuruFocus
AGEN Stock TUESDAY MADNESS! (news Update) Agenus Stock Analysis Best Broker Review Challenge Cup Final 2026 (5MyfQl06Kh) - Mshale
Agenus Inc. (AGEN) Latest Stock News & Headlines - Yahoo Finance
Agenus extends $24.75 million loan maturity, adjusts payment terms with Ocean 1181 - Investing.com
Form 8K Agenus Inc For: 18 August By Investing.com - Investing.com South Africa
Agenus Extends $24.75M Term Loan to 2029 at 13% With Ocean 1181; Partly Payable in Stock - TradingView
Agenus (NASDAQ: AGEN) to pay part of 13% loan interest in stock - Stock Titan
Agenus Number of Employees 2026 | Employee Count & Headcount Data - Revelio Labs
AGEN Q2 2026 Earnings: EPS Misses Estimates by 119.61% as Shares Slide 2.32%EBITDA Estimate Trend - Vinanet
大文字化:
|
ボリューム (24 時間):